CS logo
small CS logo
HealthCare Global Enterprises Ltd

Bangalore, Karnataka, India
Cancer treatment center in Bengaluru, Karnataka
XH7Q+MVX, Kalinga Rao Rd, Sampangi Rama Nagara, Bengaluru, Karnataka 560002

About HealthCare Global Enterprises Ltd


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at HealthCare Global Enterprises Ltd


During the past decade, HealthCare Global Enterprises Ltd conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "HealthCare Global Enterprises Ltd" #1 sponsor was "Pfizer" with 4 trials, followed by "HealthCare Global Enterprise Ltd." with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

Clinical Trials Conditions at HealthCare Global Enterprises Ltd


According to Clinical.Site data, the most researched conditions in "HealthCare Global Enterprises Ltd" are "Advanced Breast Cancer" (1 trials), "Anterior Tongue Squamous Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Buccal Mucosa Cancer" (1 trials). Many other conditions were trialed in "HealthCare Global Enterprises Ltd" in a lesser frequency.

Clinical Trials Intervention Types at HealthCare Global Enterprises Ltd


Most popular intervention types in "HealthCare Global Enterprises Ltd" are "Drug" (10 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "5FU" (1 trials), "Amivantamab" (1 trials), "Bevacizumab" (1 trials) and "Bevacizumab-EU" (1 trials). Other intervention names were less common.

Clinical Trials Genders at HealthCare Global Enterprises Ltd


The vast majority of trials in "HealthCare Global Enterprises Ltd" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at HealthCare Global Enterprises Ltd


Currently, there are NaN active trials in "HealthCare Global Enterprises Ltd". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in HealthCare Global Enterprises Ltd, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HealthCare Global Enterprises Ltd, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".